Literature DB >> 9585602

X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.

J Rae1, P E Newburger, M C Dinauer, D Noack, P J Hopkins, R Kuruto, J T Curnutte.   

Abstract

Chronic granulomatous disease (CGD) is a hereditary disorder of host defense due to absent or decreased activity of phagocyte NADPH oxidase. The X-linked form of the disease derives from defects in the CYBB gene, which encodes the 91-kD glycoprotein component (termed "gp91-phox") of the oxidase. We have identified the mutations in the CYBB gene responsible for X-linked CGD in 131 consecutive independent kindreds. Screening by SSCP analysis identified mutations in 124 of the kindreds, and sequencing of all exons and intron boundary regions revealed the other seven mutations. We detected 103 different specific mutations; no single mutation appeared in more than seven independent kindreds. The types of mutations included large and small deletions (11%), frameshifts (24%), nonsense mutations (23%), missense mutations (23%), splice-region mutations (17%), and regulatory-region mutations (2%). The distribution of mutations within the CYBB gene exhibited great heterogeneity, with no apparent mutational hot spots. Evaluation of 87 available mothers revealed X-linked carrier status in all but 10. The heterogeneity of mutations and the lack of any predominant genotype indicate that the disease represents many different mutational events, without a founder effect, as is expected for a disorder with a previously lethal phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585602      PMCID: PMC1377153          DOI: 10.1086/301874

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  61 in total

1.  A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome.

Authors:  R A BRIDGES; H BERENDES; R A GOOD
Journal:  AMA J Dis Child       Date:  1959-04

2.  Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.

Authors:  R A Ezekowitz; S H Orkin; P E Newburger
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

3.  Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b.

Authors:  C A Parkos; M C Dinauer; L E Walker; R A Allen; A J Jesaitis; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

4.  A role for exon sequences and splice-site proximity in splice-site selection.

Authors:  R Reed; T Maniatis
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

5.  Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location.

Authors:  B Royer-Pokora; L M Kunkel; A P Monaco; S C Goff; P E Newburger; R L Baehner; F S Cole; J T Curnutte; S H Orkin
Journal:  Nature       Date:  1986 Jul 3-9       Impact factor: 49.962

6.  Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus.

Authors:  D Frey; M Mächler; R Seger; W Schmid; S H Orkin
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

7.  Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization.

Authors:  D Ginsburg; R I Handin; D T Bonthron; T A Donlon; G A Bruns; S A Latt; S H Orkin
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

8.  Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma.

Authors:  R A Ezekowitz; M C Dinauer; H S Jaffe; S H Orkin; P E Newburger
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

9.  Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides.

Authors:  H Youssoufian; S E Antonarakis; W Bell; A M Griffin; H H Kazazian
Journal:  Am J Hum Genet       Date:  1988-05       Impact factor: 11.025

10.  Activation of neutrophil NADPH oxidase in a cell-free system. Partial purification of components and characterization of the activation process.

Authors:  J T Curnutte; R Kuver; P J Scott
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

View more
  38 in total

Review 1.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

2.  Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.

Authors:  Yuka Okura; Masafumi Yamada; Futoshi Kuribayashi; Ichiro Kobayashi; Tadashi Ariga
Journal:  J Clin Immunol       Date:  2015-02-10       Impact factor: 8.317

3.  Stimulation of gp91 phagocytic oxidase and reactive oxygen species in neutrophils by an avirulent Salmonella enterica serovar infantis strain protects gnotobiotic piglets from lethal challenge with serovar Typhimurium strain F98 without inducing intestinal pathology.

Authors:  Neil Foster; Scott Hulme; Margaret Lovell; Katharine Reed; Paul Barrow
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Gene correction of HAX1 reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cells.

Authors:  Erik Pittermann; Nico Lachmann; Glenn MacLean; Stephan Emmrich; Mania Ackermann; Gudrun Göhring; Brigitte Schlegelberger; Karl Welte; Axel Schambach; Dirk Heckl; Stuart H Orkin; Tobias Cantz; Jan-Henning Klusmann
Journal:  Blood Adv       Date:  2017-06-02

Review 5.  Oxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: a role of NADPH oxidase 2.

Authors:  Sarah Cahill-Smith; Jian-Mei Li
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

6.  Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements.

Authors:  Anne M Sanders; John R Stehle; Michael J Blanks; Gregory Riedlinger; Jung W Kim-Shapiro; Arta M Monjazeb; Jonathan M Adams; Mark C Willingham; Zheng Cui
Journal:  BMC Cancer       Date:  2010-03-31       Impact factor: 4.430

7.  Induction of antimicrobial pathways during early-phase immune response to Salmonella spp. in murine macrophages: gamma interferon (IFN-gamma) and upregulation of IFN-gamma receptor alpha expression are required for NADPH phagocytic oxidase gp91-stimulated oxidative burst and control of virulent Salmonella spp.

Authors:  N Foster; S D Hulme; P A Barrow
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease.

Authors:  C B Foster; T Lehrnbecher; F Mol; S M Steinberg; D J Venzon; T J Walsh; D Noack; J Rae; J A Winkelstein; J T Curnutte; S J Chanock
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

9.  Essential role of nuclear factor-kappaB for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes.

Authors:  Marcos Luengo-Blanco; Carolina Prando; Jacinta Bustamante; Walmir Cutrim Aragão-Filho; Paulo Vitor Soeiro Pereira; Jussara Rehder; Carolyn Padden; Jean-Laurent Casanova; Peter E Newburger; Antonio Condino-Neto
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

10.  Molecular analysis of X-linked chronic granulomatous disease in five unrelated Korean patients.

Authors:  Heung-Bum Oh; Joon Seok Park; Woochang Lee; Soo Jin Yoo; Jin Hyuk Yang; Sun-Young Oh
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.